Study on the treatment of biliary complications after liver transplantation by endoscopic retrograde cholangiopancreatography
内镜逆行胰胆管造影术治疗肝移植术后胆道并发症的研究

摘要

目的 探讨内镜逆行胰胆管造影术（ERCP）在肝移植术后胆道并发症治疗中的价值。方法 回顾性分析2022年1月—2023年1月本院收治的50例肝移植术后胆道并发症患者的临床资料，所有患者均接受ERCP治疗，根据并发症类型实施针对性干预。观察肝功能指标变化、症状缓解时间及并发症发生率。结果 TBIL、DBIL、ALT、AST水平及黄疸消退、腹痛缓解、发热消退时间较治疗前均下降（P<0.05），并发症发生率10.00%，经对症治疗后均痊愈。结论 ERCP治疗肝移植术后胆道并发症具有改善肝功能，症状缓解迅速、创伤小、安全性高等优势，值得推广。

Abstract

Objective To explore the value of endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of biliary complications after liver transplantation.
Methods A retrospective analysis was conducted on the clinical data of 50 patients with biliary complications after liver transplantation admitted to our hospital from January 2022 to January 2023. All patients received ERCP treatment, and targeted intervention was implemented based on the types of complications. Observe the changes of liver function indicators, the time of symptom relief and the incidence of complications.
Results The levels of TBIL, DBIL, ALT, AST, as well as the time for jaundice regression, abdominal pain relief, and fever regression all decreased compared with those before treatment (P<0.05). The incidence of complications was 10.00%, and all patients recovered after symptomatic treatment.
Conclusion   ERCP for the treatment of biliary complications after liver transplantation has the advantages of improving liver function, rapid symptom relief, less trauma and high safety, and is worthy of promotion.